Christopher Rovaldi insider trades

Open-market stock purchases and sales by Christopher Rovaldi, Chief Operating Officer at Keros Therapeutics, Inc, from SEC Form 4 filings since Sep 12, 2017.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • KROS Keros Therapeutics, Inc: 6 sales, last Feb 18, 2025
  • XLRN Acceleron Pharma Inc: 8 sales, last Apr 3, 2018

Get free alerts when Christopher Rovaldi files a new trade →